These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 11419173
1. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI. Alamo L, Fischer U. Eur Radiol; 2001; 11(6):970-7. PubMed ID: 11419173 [Abstract] [Full Text] [Related]
2. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities. Weind KL, Maier CF, Rutt BK, Moussa M. Radiology; 1998 Aug; 208(2):477-83. PubMed ID: 9680579 [Abstract] [Full Text] [Related]
3. The use of breast ultrasound color Doppler vascular pattern morphology improves diagnostic sensitivity with minimal change in specificity. Svensson WE, Pandian AJ, Hashimoto H. Ultraschall Med; 2010 Oct; 31(5):466-74. PubMed ID: 20094978 [Abstract] [Full Text] [Related]
4. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience. Huber S, Helbich T, Kettenbach J, Dock W, Zuna I, Delorme S. Radiology; 1998 Aug; 208(2):485-9. PubMed ID: 9680580 [Abstract] [Full Text] [Related]
5. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves]. Menna S, Di Virgilio MR, Burke P. Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204 [Abstract] [Full Text] [Related]
6. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI. Wang S, Delproposto Z, Wang H, Ding X, Ji C, Wang B, Xu M. PLoS One; 2013 Jun; 8(7):e67731. PubMed ID: 23844077 [Abstract] [Full Text] [Related]
7. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results. Jung EM, Jungius KP, Rupp N, Gallegos M, Ritter G, Lenhart M, Clevert DA, Kubale R. Clin Hemorheol Microcirc; 2005 Jun; 33(2):109-20. PubMed ID: 16151258 [Abstract] [Full Text] [Related]
8. [Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography]. Knopp MV, Himmelhan N, Radeleff J, Junkermann H, Hess T, Sinn HP, Brix G. Radiologe; 2002 Apr; 42(4):280-90. PubMed ID: 12063736 [Abstract] [Full Text] [Related]
9. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Ntziachristos V, Yodh AG, Schnall MD, Chance B. Neoplasia; 2002 Apr; 4(4):347-54. PubMed ID: 12082551 [Abstract] [Full Text] [Related]
10. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA. Schedel H, Oellinger H, Kohlschein P, Siewert C, Hadijuana J, Blohmer JU, Kissner T, Felix R. Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495 [Abstract] [Full Text] [Related]
11. [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status]. Huber S, Delorme S, Zuna I. Radiologe; 1998 May; 38(5):390-3. PubMed ID: 9646345 [Abstract] [Full Text] [Related]
12. Ductal carcinoma in situ: is there a role for MRI? Zuiani C, Francescutti GE, Londero V, Zunnui I, Bazzocchi M. J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661 [Abstract] [Full Text] [Related]
13. [Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers]. Aichinger U, Schulz-Wendtland R, Krämer S, Lell M, Bautz W. Rofo; 2002 Nov; 174(11):1395-401. PubMed ID: 12424666 [Abstract] [Full Text] [Related]
14. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging. Kvistad KA, Lundgren S, Fjøsne HE, Smenes E, Smethurst HB, Haraldseth O. Acta Radiol; 1999 Jan; 40(1):45-51. PubMed ID: 9973902 [Abstract] [Full Text] [Related]
15. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging. Imamura T, Isomoto I, Sueyoshi E, Yano H, Uga T, Abe K, Hayashi T, Honda S, Yamaguchi T, Uetani M. Magn Reson Med Sci; 2010 Jan; 9(4):217-25. PubMed ID: 21187691 [Abstract] [Full Text] [Related]
16. Videodensitometry in the examination of focal breast lesions after injection of an ultrasound contrast agent. Blohmer JU, Reinhardt M, Schmalisch G, Lichtenegger W, Hausschild M, Kümmel S, Fischer T, Ohlinger R, Thomas A. Anticancer Res; 2006 Jan; 26(2C):1691-8. PubMed ID: 16617563 [Abstract] [Full Text] [Related]
17. [What is the role of Doppler color sonography associated with echo-signal enhancing levovist in complementary breast diagnosis?]. Grüner C, Schönwälder A, Schulz-Wendtland R, Lang N, Bautz W. Aktuelle Radiol; 1998 Mar; 8(2):58-62. PubMed ID: 9592578 [Abstract] [Full Text] [Related]
18. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions. Schneider P, Piper S, Schmitz CH, Schreiter NF, Volkwein N, Lüdemann L, Malzahn U, Poellinger A. Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043 [Abstract] [Full Text] [Related]
19. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682 [Abstract] [Full Text] [Related]
20. D-galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions. Schroeder RJ, Maeurer J, Vogl TJ, Hidajat N, Hadijuana J, Venz S, Weber S, Felix R. Invest Radiol; 1999 Feb; 34(2):109-15. PubMed ID: 9951790 [Abstract] [Full Text] [Related] Page: [Next] [New Search]